Optimizing Medical Affairs’ Role in Immunology Launches

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Medical Affairs Product Launch in Immunology: Roles, Collaboration, and Evolution”

STUDY OVERVIEW

In the fast-paced and complex world of immunology, product launches demand more than just coordination—they require Medical Affairs to assume a leadership role that spans scientific expertise and strategic collaboration. Their ability to synthesize multifaceted scientific data and communicate it clearly to a wide range of stakeholders is vital for the success of these launches.

This benchmarking study by Best Practices, LLC explores how Medical Affairs is evolving within the immunology space, particularly in response to emerging scientific breakthroughs and the shifting dynamics of the therapeutic landscape. The study provides insights into the critical leadership functions, cross-functional coordination, and strategic adaptability necessary to drive successful immunology product launches.

KEY TOPICS

Medical Leadership Roles and Launch Activity Effectiveness in Immunology
Ensuring Cross-functional Alignment and Collaboration in Immunology Launches
Adopting to Ongoing Changes in Medical Landscape

KEY METRICS

Medical Affairs’ leadership role in immunology launches
Optimizing Medical Affairs launch activities in immunology
Improvement areas for Medical Affairs around immunology launches
Medical Affairs’ internal collaboration for immunology launch success
Medical Affairs’ cross-functional team role in immunology product launches

SAMPLE KEY FINDINGS

Internal Group Collaboration: Medical collaborates early and often with cross-functional launch teams (95%) through clearly defined roles, responsibilities, and expectations (70%) to ensure successful immunology launches.

METHODOLOGY

This benchmarking study engaged 23 Medical leaders from 16 leading life sciences organizations. The study insights are drawn primarily from Medical Directors and upper management executives, representing nearly 80% of the benchmark class.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Academic; Research; Biotech; Chemical; Consulting; Consumer Products; Health Care; Medical Device; Science

Companies Profiled:
AstraZeneca; ASC Therapeutics; Boehringer Ingelheim; Duke University and Health System; EMD Serono; Genentech; GlaxoSmithKline ; Gr�nenthal; Helsinn; MEDiSTRAVA; Novartis; Pfizer; Pixacore; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies; Thermo Fisher Scientific

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Medical Affairs Product Launch in Immunology: Roles, Collaboration, and Evolution

ID: 5823

Features:

Pages/Slides: 31

Published: 2024

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6DDA9D388478463C200258B9000431CEA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-affairs-product-launch-in-immunology-roles-collaboration-evolution?opendocument
18
19opendocument
203.238.82.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB